Latest data from January 14, 2022
Number of Health Center respondents = 17 (77% of all Health Centers)
Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.
Patients Tested
| Metrics | Value |
|---|---|
| Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 | 11,861 |
| Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) | 99.75% |
| Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 | 3,568 |
| Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) | 99.83% |
Patients by Race and Ethnicity
| Race/Ethnicity | Patients Tested, Virus Detection (PCR, Antigen)2 | Patients Tested Positive, Virus Detection (PCR, Antigen)2 |
|---|---|---|
| White, Non-Hispanic/Latino Patients | 0.25% | 0.17% |
| White, Hispanic/Latino Patients | 49.11% | 49.89% |
| Black/African American, Non-Hispanic/Latino Patients | 0.00% | 0.00% |
| Black/African American, Hispanic/Latino Patients | 5.90% | 5.02% |
| Asian Patients3 | 0.00% | 0.00% |
| American Indian/Alaska Native Patients3 | 0.00% | 0.00% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.00% | 0.06% |
| Patients with More Than One Race3 | 33.46% | 31.59% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 11.04% | 13.14% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 0.01% | 0.00% |
| Unreported/Refused to Report Race and Ethnicity | 0.22% | 0.14% |
Patients Vaccinated
| Metrics | Value |
|---|---|
| COVID-19 Immunization Series Initiated | 1,136 |
| Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization | 100.00% |
| COVID-19 Immunization Series Completed | 1,218 |
| Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization | 99.26% |
| COVID-19 Immunization Series Additional | 9,914 |
| Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine | 99.93% |
Vaccinations by Race and Ethnicity
| Race/Ethnicity | Patient COVID-19 Immunization Series Initiated2 | Patient COVID-19 Immunization Series Completed2 | Patient COVID-19 Immunization Series Additional2 |
|---|---|---|---|
| White, Non-Hispanic/Latino Patients | 0.00% | 0.74% | 0.07% |
| White, Hispanic/Latino Patients | 56.95% | 43.51% | 50.04% |
| Black/African American, Non-Hispanic/Latino Patients | 0.00% | 0.00% | 0.00% |
| Black/African American, Hispanic/Latino Patients | 3.87% | 6.40% | 7.01% |
| Asian Patients3 | 0.09% | 0.00% | 0.01% |
| American Indian/Alaska Native Patients3 | 0.44% | 0.16% | 0.19% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.09% | 0.00% | 0.19% |
| Patients with More Than One Race3 | 31.51% | 32.27% | 37.23% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 6.87% | 16.58% | 5.18% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 0.00% | 0.00% | 0.00% |
| Unreported/Refused to Report Race and Ethnicity | 0.18% | 0.33% | 0.07% |
Testing Logistics
Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)
| Metrics | Value |
|---|---|
| Less Than 1 Hour | 17.65% |
| 1 to 24 Hours | 58.82% |
| More Than 24 Hours | 23.53% |
| N/A | 0.00% |
Vaccine Logistics
Challenges in Deploying the COVID Vaccine
| Metrics | Value |
|---|---|
| Financial reimbursement for costs associated with vaccine administration | 0.00% |
| Staffing to administer the vaccine | 11.76% |
| Vaccine confidence | 0.00% |
| Vaccine storage capacity | 0.00% |
| Vaccine supply | 17.65% |
| Other | 5.88% |
| None | 64.71% |
Operations and Staff
| Metrics | Value |
|---|---|
| COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program | 29.41% |
| Average Percent of Health Center Visits Conducted Virtually | 24.41% |
Mobile Vans, Pop-Up Clinics, and School-Based Sites
| Metrics | Value |
|---|---|
| Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics | 47.06% |
| Number of Mobile Van Sites | 8 |
| Number of Pop-up Clinics | 24 |
| Number of School-Based Vaccination Sites | 1 |
| Number of Family Vaccination Clinics | 10 |
Monoclonal Antibody Therapy
Methods in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Direct provision of monoclonal antibody therapies | 5.88% |
| Refer patients to another organization that provides monoclonal antibody therapies | 52.94% |
| None | 41.18% |
Challenges in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Access to therapeutics | 11.76% |
| Patient awareness/education | 0.00% |
| Staffing capacity | 0.00% |
| Therapy administration/onsite logistics | 29.41% |
| Other | 0.00% |
| None | 58.82% |
Test Kit Distribution
| Metrics | Value |
|---|---|
| Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program | 7 |
| Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program | 12,671 |
Test Kit Distribution Methods4
| Metrics | Value |
|---|---|
| Provide to Existing Health Center Patients | 71.43% |
| Provide to General Public Who Came to the Health Center | 85.71% |
| Provide at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) | 14.29% |
| Provide at Other Community Events | 28.57% |
| Provide through direct outreach to specific populations (i.e., individuals experiencing homelessness, MSAWs, residents of public housing, individuals with limited English proficiency) | 14.29% |
| Other | 14.29% |
Oral Antiviral Medication Distribution
| Metrics | Value |
|---|---|
| Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program | 0 |
| Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication5 | - |
Oral Antiviral Medication Distribution by Race and Ethnicity5
| Race/Ethnicity | Value |
|---|---|
| White, Non-Hispanic/Latino Patients | - |
| White, Hispanic/Latino Patients | - |
| Black/African American, Non-Hispanic/Latino Patients | - |
| Black/African American, Hispanic/Latino Patients | - |
| Asian Patients3 | - |
| American Indian/Alaska Native Patients3 | - |
| Native Hawaiian/Other Pacific Islander Patients3 | - |
| Patients with More Than One Race3 | - |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | - |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | - |
| Unreported/Refused to Report Race and Ethnicity | - |
Oral Antiviral Medication Distribution by Special/Vulnerable Population5
| Metrics | Value |
|---|---|
| Migratory/Agricultural Workers | - |
| Patients Experiencing Homelessness | - |
| Patients Who Are Residents of Public Housing | - |
| Patients with Limited English Proficiency | - |
| Children Under 18 Years of Age | - |
1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.
2 Percentages may not add to 100% due to rounding to the hundredths.
3 Includes Hispanic/Latino and Non-Hispanic/Latino.
4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.
5 Percentages are calculated using the number of health centers that have distributed courses of COVID-19 oral antiviral medication received through the HRSA Health Center COVID-19 Therapeutics Program as the denominator.
